Indraprastha Medical Corporation Ltd

Indrapr.Medical Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Indraprastha Medical Corporation Ltd

₹ 480 -0.68%
13 Dec - close price
delhi.apollohospitals.com BSE: 532150 NSE: INDRAMEDCO
About

Incorporated in 1988 as a JV between Apollo Hospitals Enterprise Ltd. (AHEL) and the Delhi Government, Indraprastha Medical Corporation Ltd. is a super speciality tertiary care hospital in New Delhi. The Co. currently has 52 speciality departments. [1]

Key Points

JV of Apollo
IMCL is a JV between Apollo Hospital (22%) and the State Government of Delhi (26%), and has presence in the NCR with two facilities, a 718-bedded facility in Sarita Vihar (operational since 1996) and a 46-bedded facility in Noida (since 2006). [1]

Website BSE NSE
  • Market Cap ₹ 4,399 Cr.
  • Current Price ₹ 480
  • High / Low ₹ 530 / 154
  • Stock P/E 29.8
  • Book Value ₹ 57.2
  • Dividend Yield 0.94 %
  • ROCE 38.4 %
  • ROE 29.1 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.
  • Company has delivered good profit growth of 33.7% CAGR over last 5 years
  • Company has a good return on equity (ROE) track record: 3 Years ROE 25.4%
  • Company has been maintaining a healthy dividend payout of 34.8%

Cons

  • Stock is trading at 8.39 times its book value

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Healthcare

Part of BSE Healthcare BSE SmallCap BSE Allcap

Edit Columns
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
233 237 216 263 284 277 274 307 317 306 315 348 350
208 205 188 226 241 240 241 259 267 259 266 281 286
Operating Profit 25 31 28 37 44 37 33 47 50 47 48 67 64
OPM % 11% 13% 13% 14% 15% 13% 12% 15% 16% 15% 15% 19% 18%
0 1 2 1 1 3 5 4 4 4 5 5 6
Interest 1 1 1 1 1 1 1 1 1 1 2 2 2
Depreciation 9 9 9 10 10 10 10 10 10 10 10 11 11
Profit before tax 16 22 20 27 34 29 27 40 44 41 42 60 57
Tax % 26% 28% 24% 24% 26% 29% 27% 24% 25% 28% 25% 25% 26%
12 16 15 20 25 21 20 30 33 29 31 45 42
EPS in Rs 1.32 1.74 1.66 2.21 2.74 2.28 2.16 3.33 3.58 3.21 3.40 4.88 4.63
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
607 678 714 755 766 753 788 831 613 888 1,099 1,245 1,319
528 587 630 675 686 678 706 743 572 768 947 1,050 1,092
Operating Profit 79 91 85 80 79 74 82 87 41 120 152 195 226
OPM % 13% 13% 12% 11% 10% 10% 10% 11% 7% 14% 14% 16% 17%
1 1 1 1 -0 -1 -1 -0 -0 -3 9 16 20
Interest 9 10 8 7 8 9 7 6 3 3 4 4 6
Depreciation 26 28 28 35 31 31 30 33 33 35 39 40 42
Profit before tax 45 54 50 39 41 34 45 48 4 79 117 166 199
Tax % 37% 35% 34% 37% 36% 38% 36% 9% 46% 26% 26% 25%
29 35 32 24 26 21 28 44 2 59 86 124 148
EPS in Rs 3.14 3.87 3.54 2.66 2.86 2.30 3.10 4.76 0.25 6.39 9.40 13.52 16.12
Dividend Payout % 51% 47% 51% 68% 63% 65% 52% 0% 0% 39% 32% 33%
Compounded Sales Growth
10 Years: 6%
5 Years: 10%
3 Years: 27%
TTM: 12%
Compounded Profit Growth
10 Years: 13%
5 Years: 34%
3 Years: 258%
TTM: 42%
Stock Price CAGR
10 Years: 25%
5 Years: 66%
3 Years: 81%
1 Year: 158%
Return on Equity
10 Years: 17%
5 Years: 20%
3 Years: 25%
Last Year: 29%

Balance Sheet

Figures in Rs. Crores

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 92 92 92 92 92 92 92 92 92 92 92 92 92
Reserves 79 95 103 132 139 141 152 176 181 234 288 386 433
73 63 50 52 67 66 21 4 3 5 2 34 33
194 199 196 185 160 134 157 177 157 131 173 212 249
Total Liabilities 438 449 442 460 458 432 422 449 432 462 555 723 806
300 293 286 301 296 294 280 303 283 277 275 347 341
CWIP 0 2 3 3 0 0 1 0 3 0 3 0 0
Investments 0 0 0 0 0 0 0 0 0 0 0 0 0
138 154 153 157 163 138 141 146 145 185 278 376 465
Total Assets 438 449 442 460 458 432 422 449 432 462 555 723 806

Cash Flows

Figures in Rs. Crores

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
67 58 64 62 28 48 75 86 27 94 144 200
-54 -22 -29 -33 -22 -30 -17 -40 -19 -74 -108 -158
-13 -36 -35 -30 -5 -17 -44 -43 -3 -3 -26 -32
Net Cash Flow 0 0 -0 -0 -0 1 14 4 5 17 11 9

Ratios

Figures in Rs. Crores

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 32 35 40 41 47 41 35 35 40 18 23 17
Inventory Days
Days Payable
Cash Conversion Cycle 32 35 40 41 47 41 35 35 40 18 23 17
Working Capital Days -28 -19 -23 0 14 12 -5 -8 0 -1 -11 -24
ROCE % 23% 26% 23% 18% 17% 15% 19% 21% 3% 29% 34% 38%

Shareholding Pattern

Numbers in percentages

Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
51.00% 51.00% 51.00% 51.00% 51.00% 51.00% 51.00% 51.00% 51.00% 51.00% 51.00% 51.00%
0.18% 0.14% 0.09% 0.15% 0.77% 0.27% 0.37% 0.81% 0.95% 1.08% 1.70% 2.64%
0.02% 0.02% 0.02% 0.02% 0.00% 0.00% 0.00% 6.71% 6.36% 4.91% 3.14% 3.19%
48.80% 48.84% 48.89% 48.83% 48.22% 48.72% 48.62% 41.49% 41.69% 43.01% 44.14% 43.16%
No. of Shareholders 57,25456,54055,29055,28752,76049,83348,63047,86551,44854,15855,10364,671

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings